Heading into the second quarter, TheStreet's Jim Cramer believes stocks might be a little bit cheaper than investors realize, and he sees a lot that he likes, including Johnson & Johnson (JNJ) , IBM (IBM) and Alphabet (GOOG) . Cramer said those stocks will benefit from the weaker dollar. Cramer points out while investors should have their shopping lists ready, they should also realize the opportunities will be on a case by case basis. 'You've got Delta (DAL) , American (AAL) , United Continental (UAL) selling at seven times earnings,' said Cramer. 'Now you've got a Clorox (CLX) that's selling at a very high multiple or a Kimberly (KMB) , but those are companies, particularly Kimberly, that can really benefit from a weaker dollar.' Cramer notes that corporate guidance had been crimped by a strong U.S. dollar in the first quarter, but that could be ending.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.